Welcome to the 8th World CNS Series 2020: Targeting Neurodegenerative Diseases
Debate, Discuss & Refresh Neurodegenerative Drug Development
The 8th World CNS Summit returns to Boston in 2020, uniting industry stakeholders to learn how to overcome their translational challenges, share their progress and network for future collaborations to accelerate the development of successful neurodegenerative therapeutics.
The challenge of developing clinically effective therapeutics to treat the huge unmet need caused by neurodegeneration is as exciting as ever.
Despite the lack of clinical trial success, new investments are being made in forward-thinking biotechs, digital and blood-based biomarker technologies are advancing, new targets are emerging, and gene therapy is taking the limelight.
Don’t miss your opportunity to join over 150 fellow CNS experts from Biogen, AbbVie, Sanofi and more, and immerse yourself in the neurodegenerative community to help refresh the neurodegenerative approach and challenge traditional thinking to advance clinical progress.
|“Great meeting that has the right balance of science, drug discovery & development, and networking” - Jonathan Levenson, Senior Director, Proclara BioSciences|
|“High level, focused meeting, with overall very interesting presentations and discussion by decision makers in CNS R&D”- Johan Luthman, VP of Clinical Development, Eisai|
|"Outstanding conference" - Richard Wyse, Director of R&D, The Cure Parkinson’s Trust|